Bridgeway Capital Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-6,400
| Closed | -$338K | – | 1396 |
|
|
2020
Q3 | $338K | Buy |
6,400
+200
| +3% | +$12.3K | 0.01% | 1023 |
|
|
2020
Q2 | $380K | Buy |
+6,200
| New | +$359K | 0.01% | 951 |
|
|
2020
Q1 | – | Sell |
-9,830
| Closed | -$560K | – | 1395 |
|
|
2019
Q4 | $560K | Hold |
9,830
| – | – | 0.01% | 933 |
|
|
2019
Q3 | $526K | Hold |
9,830
| – | – | 0.01% | 935 |
|
|
2019
Q2 | $587K | Sell |
9,830
-3,300
| -25% | -$208K | 0.01% | 927 |
|
|
2019
Q1 | $818K | Sell |
13,130
-3,500
| -21% | -$232K | 0.01% | 837 |
|
|
2018
Q4 | $1.01M | Sell |
16,630
-26,900
| -62% | -$1.61M | 0.01% | 725 |
|
|
2018
Q3 | $2.55M | Buy |
43,530
+2,130
| +5% | +$109K | 0.02% | 552 |
|
|
2018
Q2 | $1.86M | Buy |
41,400
+12,900
| +45% | +$555K | 0.02% | 664 |
|
|
2018
Q1 | $1.26M | Buy |
+28,500
| New | +$1.2M | 0.01% | 757 |
|
|
2017
Q2 | – | Sell |
-7,314
| Closed | -$401K | – | 1493 |
|
|
2017
Q1 | $401K | Hold |
7,314
| – | – | ﹤0.01% | 1129 |
|
|
2016
Q4 | $407K | Sell |
7,314
-17,600
| -71% | -$846K | 0.01% | 1150 |
|
|
2016
Q3 | $1.14M | Hold |
24,914
| – | – | 0.02% | 748 |
|
|
2016
Q2 | $995K | Hold |
24,914
| – | – | 0.02% | 783 |
|
|
2016
Q1 | $868K | Sell |
24,914
-50
| -0.2% | -$1.83K | 0.01% | 826 |
|
|
2015
Q4 | $1.07M | Hold |
24,964
| – | – | 0.02% | 726 |
|
|
2015
Q3 | $1.09M | Sell |
24,964
-3,400
| -12% | -$183K | 0.02% | 710 |
|
|
2015
Q2 | $1.46M | Sell |
28,364
-400
| -1% | -$17.1K | 0.03% | 631 |
|
|
2015
Q1 | $1.13M | Hold |
28,764
| – | – | 0.02% | 740 |
|
|
2014
Q4 | $1.11M | Hold |
28,764
| – | – | 0.03% | 731 |
|
|
2014
Q3 | $1.01M | Sell |
28,764
-50
| -0.2% | -$1.47K | 0.03% | 748 |
|
|
2014
Q2 | $777K | Buy |
28,814
+100
| +0.3% | +$2.6K | 0.02% | 887 |
|
|
2014
Q1 | $744K | Hold |
28,714
| – | – | 0.02% | 893 |
|
|
2013
Q4 | $622K | Hold |
28,714
| – | – | 0.02% | 938 |
|
|
2013
Q3 | $559K | Buy |
28,714
+8,750
| +44% | +$155K | 0.02% | 975 |
|
|
2013
Q2 | $311K | Buy |
+19,964
| New | +$321K | 0.01% | 1158 |
|
Other funds holding BSTC
Bridgeway Capital Management's BSTC Position: Q4 2020 in Review
Bridgeway Capital Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 6,400 shares — an estimated $338K sold.
Bridgeway Capital Management first reported a position in BSTC in Q2 2013 and held it in 26 quarters. The position peaked at $2.55M in Q3 2018. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- Bridgeway Capital Management reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- Bridgeway Capital Management sold 6,400 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $338K.
- Bridgeway Capital Management first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and held it in 26 quarters.
- Bridgeway Capital Management's BioSpecifics Technologies Corp. position peaked at $2.55M in Q3 2018.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on Bridgeway Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.